Abstract. Delta-like-1 (Dlk1, also Pref-1), a transmembrane and secreted protein, is a member of the epidermal growth factor-like family, homologous to Notch/Delta/Serrate. We found that the expression of Dlk1 was up-regulated in CD34 + cells from patients with myelodysplastic syndrome (MDS) by analyzing the gene expression profiles determined by microarray. The expression levels of Dlk1 mRNA frequently observed higher in the bone marrow mononuclear cells of MDS patients was confirmed by real-time RT-PCR. Forced expression of Dlk1 in transfected K562 cells enhanced proliferation, affected apoptosis induced by As 2 O 3 , and also influenced cell cycle induced by 12-O-tetra decanoylphorbol-acetate (TPA). By using the same experimental system we found that forced expression of Dlk1 increased the mRNA levels of HES1. It also inhibited p38 phosphorylation in transfected K562 cells treated with TPA. These results warrant further investigation of the role of Dlk1 in abnormal hematopoiesis in MDS.
Introduction
Myelodysplastic syndrome (MDS) is a clonal hematologic disorder characterized clinically and morphologically by ineffective hematopoiesis (1) . Its features include refractory cytopenia, dysplastic cellular morphology, and a propensity toward malignant transformation (2, 3) .
The natural history of this syndrome ranges from a chronic course that may span years to a rapid course of leukemic progression. Prognosis of this disease is most closely related to the percentage of marrow myeloblasts and also to the presence and features of specific cytogenetic abnormalities (3, 4) . In general, myelodysplastic syndrome is a preleukemic condition in which the neoplastic clone has been established, but not all MDS cases terminate in acute myeloid leukemia (AML) (1) .
The molecular pathogenesis of MDS remains poorly understood. A proposal for the multistep pathogenesis of MDS suggests that the initial damage in hematopoietic stem cells can affect the expression of cell cycle-related genes, including checkpoint and mismatch repair genes, transcription factors, and tumor suppressor genes. Recent studies indicate that an increased expression of the Delta-like-1 (Dlk1) gene is frequently observed in the CD34 + cells from MDS patients (5) (6) (7) (8) .
The Dlk1 gene presents in animals from birds to mammals and is known as an imprinted gene (9) . The protein is expressed in a variety of fetal and selected adult tissues and is thought to participate in embryonic growth, hematopoiesis (10) and wound healing (11) . Moore et al (12) and Ohno et al (13) showed that Dlk1 was preferentially expressed in fetal stromal cell lines which supported hematopoietic stem cell growth, but not in nonsupportive tissues. They directly demonstrated that exogenous Dlk1 was a positive regulator of murine stem cell growth. Dlk1 also regulates the growth of pre-B cells and thymocytes (14, 15) . However, these studies focused on the effects of exogenous Dlk1 on hematopoietic cells. The functional consequences of aberrant, intrinsic Dlk1 overexpression in human hematopoietic cells are not known (16, 17) .
Materials and methods

Patients. CD34
+ cell samples isolated for microarray analysis from eight patients [comprising two cases of RA, one RAS, two RAEB, two RAEBt, and one case of chronic aplastic anemia (CAA)] (Table I) , and one healthy individual, were subjected to microarray hybridization for gene expression profiling. For real-time PCR, bone marrow mononuclear cells were collected from another 19 MDS samples (seven RA, five RAS, and seven RAEB and RAEBt samples), six AML samples and 10 other samples (one sample of pure megakaryotic anemia, four IDA, one hypercellular anemia, and one ITP sample, and samples from three healthy individuals). Patients were classified as having refractory anemia (RA) or refractory anemia with excess blasts (RAEB) according to the FAB criteria. Fold changes for the log ratios were shown. A signal log2 ratio ≥1 was considered 'up', whereas a signal log ratio ≤-1 was considered 'down'. Differential gene expression patterns were calculated using a hierarchical-clustering algorithm as a gene tree or a condition tree to display the gene expression profile (5) (6) (7) (8) . Genes of interest were selected for bioinformatics study.
Quantitative real-time RT-PCR. Quantification of RNA in bone marrow mononuclear cells by real-time PCR was performed as described previously. Briefly, 500 ng total RNA was processed directly to cDNA by reverse transcription. PCR primers and TaqMan probes were designed using Primer Express 2.0 software with published sequence data from the NCBI database. Amplification reactions contained 2 μl cDNA, 1 μl 20X buffer, 2 μl MgCl 2 4 μl 5X Q-Solution, 0.8 mM dNTPs, 2 μM primers, 1 μM probes, 1 U HotStar (Qiagen, Germany). In a final volume of 20 μl, the thermal cycling conditions were as follows: 15 min at 95˚C, followed by 40 cycles at 95˚C for 30 sec, 50˚C for 30 sec, and 72˚C for 30 sec. ß-actin was used as an active and endogenous reference to correct for differences in the amount of total RNA added to a reaction and to compensate for different levels of inhibition during reverse transcription of RNA during PCR.
Cell transfection and Western blot analysis. K562 leukemia cells were cultured in RPMI-1640 containing 10% FCS. The expression vector pcDNA-Dlk1 was constructed by placing full-length human Dlk1 cDNA into the pcDNA3.0 vector (Invitrogen). The constructs were transfected into K562 cells by lipofectamine and stable transfectants were selected for their G418 resistance (800 mg/ml). Empty vector was also transfected at the same time. The Dlk1 overexpressing clones were detected by Western blot analysis. Anti-Dlk1 polyclonal antibody (C-19) (Santa Cruz, CA, USA) and anti-actin antibody (Research Diagnostic, Flanders, USA) were applied. Anti-phosphorylated p38 and p38 antibodies were also used (Cell Signaling, USA).
Cell proliferation in liquid culture assays. Viable cells were counted using Cell Counting Kit-8 (CCK-8) beginning in 96-well plates at 2-10 3 cells/well; 10 μl CCK-8 solution was added to each well, after 2 h of incubation, the optical absorbance at 450 nm was measured. Each experiment was performed three times.
Flow cytometric analysis for cell cycles. After culture without FCS for 24 h, 5 nM 12-O-tetra decanoylphorbolacetate (TPA) (Sigma, St Louis, MO, USA) and 10% FCS were added into the cell culture followed by continuous culture for 18 h, after which cells were harvested and washed three times by 5 ml PBS/0.1% FCS wash buffer, centrifuged and aspirated. The cells were then re-suspended with 20 μg/ml PI, 500 μg/ml RNase and 0.03% NP-40 in wash buffer, and analyzed by flow cytometry (FACScan) (Becton Dickinson, Heidelberg, Germany).
Apoptosis assessment by annexin-V staining. After As 2 O 3 treatment for 3 h, cells were washed in PBS and re-suspended in 100 μl staining solution (containing annexin-V fluorescein and PI in a HEPES buffer, Annexin-V-FLUOS Staining Kit, Boehringer-Mannheim). Following incubation at room temperature for 15 min, cells were analyzed by flow cytometry. Annexin-V binds to cells which express phosphotidylserine on the outer layer of the cell membrane, and PI stains the cellular DNA of those that have a compromised cell membrane. This allows for the discrimination of live cells (unstained with either fluorochrome) from apoptotic cells (stained only with annexin-V) and necrotic cells (stained with both annexin-V and PI) (18) .
Results
Gene transcription profile of CD34 + cells. The 18,404 signal dots on the chips were filtered for the final clustering and bioinformatics analysis (Fig. 1a) . About 164 genes or ESTs were down-regulated in the CD34 + cells of all 7 MDS samples in contrast to healthy controls (Fig. 1b) , while 46 genes or ESTs were up-regulated in all 7 MDS samples compared with controls (Fig. 1c) . Twenty-three genes or ESTs were identified for their differential expression between MDS-RA or -RAS and CAA patients. Fifteen genes were highly expressed in MDS-RA and MDS-RAS samples, while they were down-regulated in CAA; eight genes were downregulated in the MDS-RA and MDS-RAS cases, while they were highly expressed in CAA samples. (Fig. 1d, Table II ). These genes are likely to be involved in the regulation of hematopoietic proliferation and differentiation. Table I . Characteristics of patients from whom samples were obtained for microarray. 
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in MDS-RAEB and RAEBt was markedly higher than that in AML (P<0.05). Among the MDS subtypes, there were no significant differences in the Dlk1 transcript levels (Fig. 1d) .
Dlk1 caused cellular proliferation of K562 cells.
To examine the effect of Dlk1 on cell proliferation, we generated K562 cells stably overexpressing Dlk1. Three stable clones expressing Dlk1 and control clones (transfer vector) were isolated (Fig. 2a) . The Dlk1 expressing clones grew faster than controls (Fig. 2b) . To elucidate the mechanisms of the action of Dlk1 on cell growth, we analyzed the levels of cell proliferation gene in these cell lines. Using RT-PCR, the HES1 were found up-regulated in these stable clones which were overexpressing Dlk1 (Fig. 2c) , while the transcriptional expression of Notch1, Notch2, NF-κB, and p21 WAF1 transcript variant 2 were no different (data not shown). In addition, no difference in the expression of ERK, JNK, and p38 at protein level was found by Western blot analysis (data not shown).
Dlk1 affects apoptosis of K562 cells induced by As 2 O 3.
Both the Dlk1-transfected and control K562 cells were treated by 0.2 μM As 2 O 3 for 3 h without FBS. The cells were stained by annexin-V and analysed by flow cytometry. Fourteen percent of the cells in control clone were positive for annexin-V staining while very few annexin-V positive stained cells were detected in the stable transfected K562 clones overexpressing Dlk1 (Fig. 3a) .
Dlk1 influences cell cycle phase distribution upon TPA induction. The cell cycle phase distribution analysis by flow cytometry on the K562 cells treated by TPA showed a markedly higher number of control clone cells in G2 phase than stable transfectant clone cells expressing exogenous Dlk1 (Fig. 3b and c) . To elucidate the relevance of the Dlk1 gene to the MAPK pathway, we analyzed the protein levels of both phosphorylated-p38 and p38 in cells exposed to TPA. In three stable K562 clones overexpressing Dlk1 the phosphorylated-p38 protein was markedly reduced compared to the control clones, while no difference was found in the p38 protein level between these two groups (Fig. 3d) .
Discussion
Gene expression profiles in the hematopoietic cells of MDS patients have been studied using microarray, by our group and others during recent years in the hope of identifying candidate genes which may assist in furthering our knowledge of the mechanisms of the development and progression of MDS. Furthermore, such genes would probably provide biomarkers in the future, facilitating the diagnosis of MDS. Our previous study identified a handful of candidate genes which were differentially expressed in the bone marrow mononuclear cells (MNCs) of MDS patients in comparison with normal controls using a cDNA microarray designed by our group (19) . The expression pattern of some of these genes, for example, the C/EBPξ gene, was confirmed by quantitative real-time RT-PCR in an expanded cohort of MDS patients (20) . However, MNCs in MDS patients may not represent the dysplastic clone due to the extremely heterogeneous entity of the disease, and the gene expression pattern of MNCs may mask the real expression profile of MDS clone. The quality of the array also influences the reliability and reproducibility of the results. In the present study, we isolated CD34 + cells from the BM of MDS patients, extracted RNA, and applied high quality Affymetrix chips to improve our results. The results of our present study are somewhat discrepant from our previous results in terms of the expression pattern of some genes. We revealed a distinct gene expression profile in MDS patients in the present study. In addition, we identified certain genes whose expression pattern may distinguish low-risk MDS from CAA and MDS-RA/RAS from MDS-RAEB patients. Among these genes displaying different expression patterns between MDS and CAA, our finding that the transcriptional level of Dlk1 is markedly increased in MDS CD34
+ cells is consistent with the results observed by other investigators (6) (7) (8) . To further explore the functional role of this gene in dysplatic hematopoiesis, we intend to concentrate our study on Dlk1 after confirming its expression pattern in a larger patient cohort. Dlk1 (Pref-1, FA1 and pG2) known as an imprinted gene residing on chromosome 14, codes for a transmembrane and secreted protein (10) . It contains a signal peptide belonging to the epidermal growth factor-like family, homologous to Notch/Delta/Serrate. Dlk1 protein has six epidermal growth factor-like repeats, a transmembrane domain, and a short intracellular tail (10), but lacks the DSL motif. In the mouse, this gene is transcribed only from the paternal allele. It contains a completely unmethylated CpG island promoter and an exonic differentially methylated region (DMR) which is hypomethylated on the maternal allele and partially methylated on the paternal allele.
The relevance of the Dlk1 gene to hematopoiesis was not studied until recently. In this study, we found that the expres- 
